Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

LIQUICHEK DIABETES CONTROL, LEVEL 1,2,3,4

K-Number: K052838 · 2005-11-09

ApplicantBio-Rad
Decision Date2005-11-09
Product CodeGGM
Advisory CommitteeHE
DecisionSubstantially Equivalent

Device Summary

LIQUICHEK DIABETES CONTROL, LEVEL 1,2,3,4 is the device name listed in this FDA 510(k) record. The listed applicant is Bio-Rad. It received FDA 510(k) clearance on 2005-11-09 under 510(k) number K052838. The device is classified under product code GGM. It was reviewed by the HE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the LIQUICHEK DIABETES CONTROL, LEVEL 1,2,3,4?

LIQUICHEK DIABETES CONTROL, LEVEL 1,2,3,4 is a medical device that received FDA 510(k) clearance on 2005-11-09. The listed applicant is Bio-Rad. The 510(k) number is K052838.

When did LIQUICHEK DIABETES CONTROL, LEVEL 1,2,3,4 receive FDA 510(k) clearance?

LIQUICHEK DIABETES CONTROL, LEVEL 1,2,3,4 received FDA 510(k) clearance on 2005-11-09, under 510(k) number K052838.

Who is the listed applicant for LIQUICHEK DIABETES CONTROL, LEVEL 1,2,3,4?

The FDA 510(k) record lists Bio-Rad as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for LIQUICHEK DIABETES CONTROL, LEVEL 1,2,3,4?

The FDA product code for LIQUICHEK DIABETES CONTROL, LEVEL 1,2,3,4 is GGM.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Bio-Rad as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K171061MRSASelect IIK122187VRESELECT CULTURE MEDIUMK103684VRESELECT CULTURE MEDIUMK093678PLATELIA ASPERGILLUS EIA MODEL 62793K100589MRSA SELECT - SKIN AND SOFT TISSUE WOUND SPECIMENSK081362PLATELIA LYME IGM

View all 319 devices →

Related Devices (Code: GGM)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K192842HemoTrol Duo Low, HemoTrol Duo Normal, HemoTrol Duo HighEurotrol B.V.K182744HemoTrol WB - Low, HemoTrol WB - Normal, HemoTrol WB - HighEurotrol B.V.K070546LYPHOCHEK DIABETES CONTROLBio-Rad LaboratoriesK070334R&D SICKLE QC CONTROLR&D Systems, Inc.K032791GLYCOHEMOSURE HBA1C CONTROLQuantimetrix Corp.K003030LYPHOCHEK HEMOGLOBIN ALC LINEARITY SETBio-Rad

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑